throbber
Page 57
`
` UNITED STATES PATENT AND TRADEMARK OFFICE
` BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`UNIFIED PATENTS INC., )
` )
` Petitioner, )
` ) Case No. IPR2018-00044
` vs. )
` ) Volume II
`VILOX TECHNOLOGIES LLC )
` ) Pages 57 to 101
` Patent Owner. )
`_________________________________)
`
` DEPOSITION OF WESLEY CHU, Ph.D.
` Marina del Rey, California
` Tuesday, November 6, 2018
`
`Reported by:
`ELIZABETH BORRELLI, CSR No. 7844, CCRR, CLR
`JOB NO. 150729
`
`TSG Reporting - Worldwide 877-702-9580
`
`1
`2
`
`3 4
`
`5
`
`6
`
`7
`
`8
`
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`25
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 1 of 45
`
`

`

`Page 58
`
` Deposition of WESLEY CHU, Ph.D., Volume
`II, taken on behalf of the Petitioner, at 4100
`Admiralty Way, Marina Del Rey, California,
`commencing at 10:03 a.m., Tuesday, November 6,
`2018, before Elizabeth Borrelli, a Certified
`Shorthand Reporter in the State of California,
`License No. 7844.
` * * *
`
`TSG Reporting - Worldwide 877-702-9580
`
`1 2 3 4 5 6 7 8
`
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 2 of 45
`
`

`

`Page 59
`
`APPEARANCES OF COUNSEL:
`
`For the Petitioner:
` HAYNES AND BOONE
` BY: JOHN EMERSON
` Attorney at Law
` 2323 Victory Avenue
` Dallas, Texas 75219
`
`For the Patent Owner:
` LAW OFFICES OF JOHN HARROP
` BY: JOHN HARROP
` Attorney at Law
` 601 Los Caminos Street
` St. Augustine, Florida 32095
`
`TSG Reporting - Worldwide 877-702-9580
`
`1
`
`2 3
`
`4
`
`5
`
`6
`
`7 8 9
`
`10
`
`11
`
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 3 of 45
`
`

`

` I N D E X
`WITNESS EXAMINATION
`WESLEY CHU, Ph.D.
`By MR. EMERSON 61
`By MR. HARROP 81
`
`Page 60
`
` R E F E R E N C E D E X H I B I T S
`
`EXHIBIT DESCRIPTION PAGE
`Exhibit 2027 Declaration of Wesley W. Chu, 61
` Ph.D. dated October 22, 2018,
` 17 pages
`Exhibit 1014 Goldberg patent, Patent No. 76
` 6,452,597, 14 pages
`
`Exhibit 1001 De Bellis patent, Patent No. 81
` 7,302,423, 69 pages
`
` INFORMATION REQUESTED
` (None)
` UNANSWERED QUESTIONS
` (None)
`
`TSG Reporting - Worldwide 877-702-9580
`
`1
`2
`3
`4
`5
`
`6 7 8
`
`9
`10
`11
`
`12
`13
`
`14
`
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 4 of 45
`
`

`

`Page 61
` MARINA DEL REY, CALIFORNIA; TUESDAY, NOVEMBER 6, 2018
` 10:03 A.M.
`
` WESLEY CHU, Ph.D.,
` having been duly administered an oath in
` accordance with CCP 2094, was examined
` and testified as follows:
`
` EXAMINATION
`BY MR. EMERSON:
` Q. So, Dr. Chu, good morning again.
` A. Good morning.
` Q. How are you?
` A. Good.
` Q. Good. Any reason why you can't give
`truthful and accurate testimony today?
` A. No.
` Q. Not on any medications ore anything like
`that?
` A. No, uh-uh.
` Q. Good. So what you have in front of you,
`the Declaration of Wesley W. Chu, Ph.D. dated
`October 22, 2018. And this is Exhibit 2027 in this
`IPR.
` Do you see that?
`
`TSG Reporting - Worldwide 877-702-9580
`
`1
`2
`
`3 4
`
`5
`6
`7
`
`8 9
`
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 5 of 45
`
`

`

`Page 62
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` A. Yes.
`BY MR. EMERSON:
` Q. And you're familiar with this document,
`right?
` A. Yes.
` Q. Did you write this?
` A. Yes.
` Q. You did?
` Did you write it by yourself?
` A. No, it was together with John.
` Q. How much time did you spend on it?
` A. Oh, like a week.
` Q. A week?
` A. Yeah.
` Q. Okay. How much -- I mean, how much time
`during that week, how many hours would you expect
`you spent on this declaration?
` A. Maybe like 40 hours.
` Q. 40 hours?
` A. Yeah.
` Q. So a full week on this, full workweek on
`this?
` A. Yeah. Off and on, yeah, yeah.
` Q. Off and on, okay.
` But the amount of time you spent working
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 6 of 45
`
`

`

`Page 63
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`on it was about 40 hours?
` A. Yeah.
` Q. Okay. So why don't turn to page 2 of 17.
`Are you there?
` A. Page 2 of 17?
` Q. Two, yes, sir. It will be to your left.
` A. 17, page --
` Q. Page 2 of 17.
` A. Oh, 2, yes, yes.
` Q. All right. Is that the one where at the
`top it says "Introduction"?
` A. Yeah.
` Q. All right. So I'm looking at -- in
`paragraph 2, you mention that you reviewed
`Exhibit 2022, which is a declaration of Joseph De
`Bellis.
` Do you see that?
` A. Yes.
` Q. All right. And Joseph De Bellis is the
`inventor of the patent that is the subject of this
`the IPR, right?
` A. Right.
` Q. Have you ever met Dr. De Bellis?
` A. Yes.
` Q. How many times?
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 7 of 45
`
`

`

`Page 64
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` A. One or two times.
` Q. One or two times?
` And when was that?
` A. Oh, many years ago.
` Q. Many years ago? Really?
` A. Yeah.
` Q. How did you -- how did you meet him?
` A. Okay. I read -- Dr. De Bellis is a
`schoolmate of my son.
` Q. Okay.
` A. We met on that occasion.
` Q. Okay. When was that?
` A. Maybe 20 years ago.
` Q. 20 years ago?
` A. Yeah.
` Q. And when you say Dr. De Bellis was a
`schoolmate of your son --
` A. Yeah.
` Q. -- was this when your son was in college?
` A. Yeah, they were schoolmate together at
`Georgetown.
` Q. At Georgetown, studying what?
` A. Medicine.
` Q. Medicine?
` A. Yeah.
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 8 of 45
`
`

`

`Page 65
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` Q. Okay. Your son's a doctor?
` A. Yeah.
` Q. What kind of doctor?
` A. Ophthalmologist.
` Q. That's right. I think we talked about
`this offline?
` A. Right, yeah.
` Q. -- at our last depo, didn't we?
` A. Right.
` Q. Okay. So how did you meet Dr. De Bellis?
`Let me back up a second.
` So your son and Dr. De Bellis were in
`medical school at Georgetown?
` A. Right.
` Q. All right. And so how did you come to
`meet Dr. De Bellis?
` A. Oh, he -- he came to -- okay. He came
`to -- to visit my son. My son was studying at
`Georgetown for two years, and last two years he
`finished medical school at UCLA. But he did come
`to -- they're friends. He came to Los Angeles to
`visit my son, and so I just casually met them.
`That's all.
` Q. Okay. When you met Dr. De Bellis, did you
`discuss any of the technology --
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 9 of 45
`
`

`

`Page 66
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` A. Nothing.
` Q. -- during --
` A. Nothing.
` Q. Okay.
` A. Just shake hands.
` Q. Sure.
` A. That's it. My son's friend, you know,
`that's it.
` Q. So let's -- I'll try to do this too.
`Let's try not to talk over each other, okay?
` A. Okay.
` Q. All right. It gets easy when we start
`talking like this, just a regular conversation, you
`know, we cut each other off.
` So do you -- do you have any firsthand
`knowledge of Dr. De Bellis conceiving the claimed
`subject matter?
` A. No, not except from the -- from the -- his
`deposition -- in his declaration.
` Q. Other than his declaration --
` A. Yeah, yeah.
` Q. -- do you have any independent knowledge
`of Dr. De Bellis's conception of the claimed subject
`matter?
` A. No.
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 10 of 45
`
`

`

`Page 67
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` Q. Other than his declaration, do you have
`any firsthand knowledge or independent knowledge of
`Dr. De Bellis reducing the claimed subject matter to
`practice?
` A. No.
` Q. Have you ever used the product that
`Dr. De Bellis allegedly developed?
` A. No.
` Q. Okay. Let's turn to page 4, please.
` Are you there?
` A. Yeah, I'm here.
` Q. And I'm going to direct your attention to
`paragraph 10.
` Do you see that?
` A. Yes.
` Q. And there in the first sentence of
`paragraph 10 you mention a PHOSITA, P-H-O-S-I-T-A.
` Do you see that?
` A. Right, right.
` Q. What's a PHOSITA?
` A. PHOSITA is a person that was -- was the --
`with the knowledge of the -- with the knowledge of
`the field and able to understand the patent and...
` Q. Okay. When we talk about a PHOSITA, are
`we referring to a particular time?
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 11 of 45
`
`

`

`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 68
` A. We would -- I think we are talking about
`when he presented claim 24, 25, at that time he
`should be able to understand and -- understand what
`this claim is and whether this could be implemented
`in practice and things like that.
` [Reporter requests clarification.]
` THE WITNESS: Could be implemented in
`practice and make judgments on.
`BY MR. EMERSON:
` Q. So we would determine -- we would
`determine a PHOSITA as of the time that the inventor
`presents his claims, right?
` A. Right.
` Q. Okay. But in this particular case, how
`would you define a PHOSITA?
` A. Well, this is a person with a computer
`science degree --
` Q. Uh-huh.
` A. -- and one year's experience, practical
`experience, in database area.
` Q. Okay. Now I'm going to stick with
`paragraph 10 --
` A. Okay.
` Q. -- but if you could turn to the next page,
`please.
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 12 of 45
`
`

`

`Page 69
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` A. Okay.
` Q. Now, on the second complete sentence, do
`you see there that it begins, "That is" --
` A. Yes.
` Q. -- comma?
` A. Yeah.
` Q. So you state there, "That is, as a PHOSITA
`would understand, neither proposed amended claim 24
`nor 25 recites or requires, 'displaying each
`truncated entry.'"
` Do you see that?
` A. Yes.
` Q. All right. And then you are comparing
`that to some language two sentences down that reads
`as follows: "The claim limitation of 'a truncated
`portion of each entry in the selected database field
`is displayed.'"
` Do you see that language?
` A. Yeah, yeah.
` Q. So my question for you is this: What is
`the difference between displaying each truncated
`entry and a truncated portion of each entry in the
`selected database field is displayed? Can you
`explain to me how those two phrases differ?
` A. Let me just -- need to read the two
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 13 of 45
`
`

`

`Page 70
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`paragraph, two sentence. Display each truncated
`entry. First is a truncated portion of each entry
`in the select database for display.
` Q. Correct.
` A. Pretty much the same.
` Q. Okay. Got it. Thank you.
` All right. Would you turn, then, to page
`7. And I'm looking -- are you there?
` A. Yeah.
` Q. I'm looking at paragraph 13?
` A. Yeah.
` Q. You have a quotation here. You are
`purporting to quote from Dr. Greenspun's
`declaration, and you have a quotation here that
`begins "Would be taught by" and ends "small in
`size."
` Do you see that?
` A. Yeah, I saw it.
` Q. Is that an accurate quotation?
` A. We can look at the exhibit to --
` Q. Sure. Actually, you know what, I don't
`have a -- I don't have a hard copy of that. Can
`I -- I can walk around and show you --
` A. Yeah, yeah.
` Q. -- on my iPad, if that's okay?
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 14 of 45
`
`

`

`Page 71
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` A. Yeah, yeah.
` MR. HARROP: Or he can walk around and
`looked at yours.
` MR. EMERSON: Oh, either way. Yeah,
`that's fine.
` MR. HARROP: So will I.
` THE WITNESS: I just want to be accurate.
`BY MR. EMERSON:
` Q. No, sure. Paragraph 13. And I don't --
`okay. So here is -- let me just make sure we're --
`let's see here. I'm on page 6, and so let me
`just -- so here we have Dr. Greenspun's dec, right?
` A. Yeah.
` Q. And you're citing to paragraph 13.
` A. Uh-huh.
` Q. Here's paragraph 13.
` A. "Small in size."
` [Reporter requests clarification.]
`BY MR. EMERSON:
` Q. Do you need it bigger?
` A. No, in here, it says "small in size," the
`words.
` Q. Right. Anyway, I was just -- it looks
`like we've got some extra language in here, turning
`back to paragraph 13 of your dec, after Kanevsky,
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 15 of 45
`
`

`

`Page 72
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`you have a semicolon, and then "Greenspun MtA,
`asserts."
` A. "If the underlying database was small in
`size."
` Q. Yeah.
` A. Yeah, that's what the --
` [Reporter requests clarification.]
` THE WITNESS: "Small in size." That's
`what this is stating in Greenspun's declaration.
`BY MR. EMERSON:
` Q. Anyway, it looks like we have a few extra
`words after -- in your quotation, after Bertram,
`right? So here, I'll even highlight it for you.
` A. "If the underlying database was small in
`size"; is that what you...
` Q. Here you've got some -- you see "Greenspun
`MtA asserts"?
` A. Yeah, it says, "if the underlying database
`was small in size."
` Q. Yeah. So it's just some extra language in
`there, right --
` A. Yeah.
` Q. -- in paragraph 13 of your --
` A. Yeah, right.
` Q. -- declaration? Just a typo?
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 16 of 45
`
`

`

`Page 73
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` A. "Would be taught by" -- oh, this
`(indecipherable.)
` [Reporter requests clarification.]
`BY MR. EMERSON:
` Q. The part that says Greenspun -- the part
`that goes, "; Greenspun MtA asserts," that's not in
`Dr. Greenspun's declaration, right?
` A. No.
` Q. No, okay.
` So let me just -- that's -- that's good.
` A. Okay.
` Q. All right. Did you -- did you proofread
`this declaration? Who was -- who was -- let me put
`this way, Dr. Chu: Who was responsible for
`proofreading this declaration?
` A. I guess I have to say I am, yeah.
` Q. Okay.
` A. But we're doing -- joining was -- was John
`and -- but -- but the idea points are mine.
` Q. Okay. All right. Let's -- let's go on to
`page 11, please.
` Are you there?
` A. Yeah.
` Q. So on page 11 --
` A. Uh-huh.
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 17 of 45
`
`

`

`Page 74
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` Q. -- this is part of paragraph 23 of your
`declaration.
` A. Yes.
` Q. And in paragraph 23 of your declaration,
`you're talking about the Goldberg reference, right?
` A. Yes.
` Q. And about halfway down the page on page
`11, you state, "Even were Goldberg." Do you see
`that sentence, begins "Even were Goldberg"?
` A. We have a lot of Goldbergs here. Can
`understand. "Even" -- yeah --
` Q. Yeah, "Even" --
` A. -- "Even were Goldberg."
` Q. Right. So that reads -- and I'll just
`read it into the record.
` A. Yeah.
` Q. "Even were Goldberg to be read to apply to
`a 'plurality of entries' (which no PHOSITA would
`understand from studying Goldberg), a PHOSITA would
`understand it because Goldberg's system is directed
`to making data 'readable' to a vehicle operator
`(driver), Goldberg simply would display each of the
`entries (adjusted in size or not adjusted) on a
`separate screen or page so that the driver could
`readily read (and grasp) the data using only brief
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 18 of 45
`
`

`

`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 75
`glances at the computer screen to avoid distraction
`from safe operation of the vehicle."
` Do you see that?
` A. Yes.
` Q. Okay. Now, your -- your declaration
`doesn't point us to anything in Goldberg that would
`support that statement, does it?
` A. In the Goldberg's patent, it does mention
`they want to be readable and for the vehicle
`operators.
` Q. Okay. So specifically what I'm talking
`about is that you don't provide any support for your
`testimony that Goldberg says to display each entry
`on a separate screen or on a separate page, correct?
` A. Well, if you don't have enough space, then
`you have to go display that on another page.
` [Reporter requests clarification.]
` THE WITNESS: Yeah, another screen. Yeah.
`BY MR. EMERSON:
` Q. Understood.
` But your declaration doesn't direct the
`reader to anything in Goldberg that says to display
`each entry on a separate screen or a separate page,
`does it?
` A. I have to look at the Goldberg's patent.
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 19 of 45
`
`

`

`Page 76
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` Q. Okay.
` A. So can maybe -- yeah.
` Q. And we can do that.
` But first I want to -- I'm talking about
`simply your declaration.
` A. Okay.
` Q. Okay?
` A. Yeah.
` Q. Now, your declaration doesn't provide
`support for your statement that Goldberg says to
`display each entry on a separate screen or a
`separate page, right?
` A. No.
` Q. No, okay.
` So here is Goldberg. And for the record,
`Goldberg is Exhibit 1014.
` MR. EMERSON: And off the record.
` (Discussion off the record.)
` THE WITNESS: I cannot specifically find
`the sentence of going to a different screen, but I
`feel that, like, if you want -- the screen is very
`small, you cannot display all the things in spite of
`the fact you can shrink the font size, then if this
`fails, then you have to use a different size, an
`additional screen to see the text. So...
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 20 of 45
`
`

`

`Page 77
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`BY MR. EMERSON:
` Q. Okay. All right.
` All right. Can you turn, please, to page
`15.
` A. Okay. Yes.
` Q. All right. So that's this -- sort of a
`claim chart you have here, right?
` A. Right.
` Q. All right. So on claim -- I'm sorry, the
`first -- the first complete row in -- on page 15,
`you have under claim limitation, "Determining a
`database schema for a database."
` A. Right.
` Q. Do you see that?
` A. Yeah.
` Q. And on the right-hand column, you state,
`"A PHOSITA would understand that a schema is
`determined in order to present the list of available
`data fields displayed in 201."
` A. Yes.
` Q. Do you see that? Okay.
` Now, here you don't explain how the schema
`is determined, do you?
` A. No.
` Q. No. Is it your opinion that if a list of
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 21 of 45
`
`

`

`Page 78
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`available data fields is displayed, that a POSITA
`would always understand that the schema was
`determined?
` A. You could use trial by error method to
`determine the schema based on the data that you
`have.
` Q. Okay.
` A. Received.
` Q. I don't think that's answering my
`question.
` A. Okay.
` MR. EMERSON: So I'll object to that as
`nonresponsive.
`BY MR. EMERSON:
` Q. So here's my question, and maybe it wasn't
`clear.
` Is it your opinion that if a list of
`available data fields is displayed, that a POSITA
`would always understand that the schema was
`determined -- regardless of the manner in which it
`was determined, would a POSITA always understand
`that the schema was determined?
` A. Well, you have -- the POSITA have to find
`a way to -- to derive the schema from the data. And
`as in the patent say there are many way you can do
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 22 of 45
`
`

`

`Page 79
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`it. One is by trial and error methods and try to
`see -- because if you look at the data, the set of
`data coming in from --
` [Reporter requests clarification.]
` THE WITNESS: -- the set of data that you
`receive, if it's relating with driving a vehicle,
`relating with --
` [Reporter requests clarification.]
` THE WITNESS: -- vehicle, and also related
`to the performance of the vehicle and things like
`that, then you can start to see this schema is
`related -- was driving a vehicle. And so you can
`construct a schema based on those information by
`trial and error methods.
`BY MR. EMERSON:
` Q. So is that a yes?
` A. Yes.
` Q. Okay.
` All right.
` A. Maybe not exactly right, you know, but I
`have to try many, many times.
` [Reporter requests clarification.]
` THE WITNESS: Trial and error but many
`times, so yeah. Maybe improve upon it so then you
`can get started.
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 23 of 45
`
`

`

`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 80
` MR. EMERSON: All right. I'll object to
`the last part of that answer as -- after I said "All
`right" as nonresponsive.
`BY MR. EMERSON:
` Q. All right. Let's stay on page 15, okay?
` A. Okay.
` Q. And I'm going to go down a couple of -- or
`three claim limitations to "determining a number of
`characters."
` Do you see that?
` A. Yes.
` Q. And then you have on the right-hand column
`a citation to the De Bellis patent.
` A. Yes.
` Q. And you list 38 different figures and
`about 10 pages of text?
` A. Uh-huh.
` Q. Is there any way that you can narrow that
`large citation down a bit? That's most of the
`patent.
` A. That's true. That's true.
` But you could just say -- just look at the
`first few, you know. Like page 7, 19. Well, I wish
`I had the patent.
` Q. Sure, I can hand you a copy. So this is
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 24 of 45
`
`

`

`Page 81
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Exhibit 1001.
` A. Yeah.
` Q. The De Bellis patent.
` THE WITNESS: Well, I will say that let's
`just look at the paragraphs 7, 8, 9. That should be
`sufficient.
`BY MR. EMERSON:
` Q. Paragraphs 7, 8 and 9?
` A. I see paragraph 7 to -- 7 -- 10 to -- 10
`to 16, 40, right, through paragraph 16, but I think
`paragraph 7, 8, and 9 should -- and beginning of 9
`should cover quite a bit as well.
` Q. Okay. So do you mean column 7, 8 and 9?
` A. Column, sorry, sorry. Not paragraph,
`column, column.
` Q. Okay. All righty, then.
` MR. EMERSON: Well, I'm going to pass the
`witness.
` MR. HARROP: Okay. Can we take a short
`break, and I'll do a redirect?
` MR. EMERSON: Sure.
` (Recess.)
` EXAMINATION
`BY MR. HARROP:
` Q. Dr. Chu, earlier in your testimony you
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 25 of 45
`
`

`

`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 82
`were asked about the content of paragraph 10 of your
`declaration. And you were directed to read a couple
`phrases or sentences from that paragraph 10.
` Would you turn to paragraph 10, please?
` A. Yeah.
` Q. Okay. Would you read -- would you read
`the entire content of paragraph 10 that's on this?
`Just read it to yourself --
` A. Okay.
` Q. -- from this page and all the way to the
`end of that sentence that ends on page 5. Read from
`here (indicating) --
` A. Here to --
` Q. -- to the end -- to the end of that
`sentence, to there (indicating). And read it to
`yourself.
` A. Here (indicating). Okay.
` Yeah.
` Q. Okay. So let's go back to the first
`sentence. Would you read that out loud, please?
` A. "A PHOSITA will understand that in
`proposed amended claims 24 and 25, the claimed
`truncation reduce characters and will result in
`collapsing the result list vertically so that the
`result list may be displayed on a terminal."
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 26 of 45
`
`

`

`Page 83
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` Q. Okay. Now, read the next sentence.
` A. "Thus, the city amend -- Armandia and
`Armonk, in the disclosed example, become 'Arm'
`therefore -- thereby reducing the number of lines by
`one."
` Q. Okay.
` A. "However" --
` Q. Let's stop -- no, that's --
` A. Okay.
` Q. That's far enough.
` So in that sentence that you just read,
`"The cities Amandia and Armonk, in the disclosed
`example, become 'Arm' thereby reducing the number of
`lines to one," what does that mean?
` A. That means you -- you trunc- -- you
`reduce -- to reduce the vertical, you reduce the
`space by one line.
` Q. Well, what does the term "Arm" stand for
`in this sentence?
` A. Arm is a truncation. It's a -- it's a --
`it's a route of Armandia and Armonk.
` Q. Is Arm a truncated portion of an entry?
` A. Yes.
` Q. Is Arm a truncated portion of Armandia?
` A. Yeah.
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 27 of 45
`
`

`

`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 84
` Q. And is Arm a truncated portion of Armonk?
` A. Yes.
` Q. Is Arm a truncated portion of both
`Armandia and Armonk?
` A. Yes.
` Q. Okay. Let's go to the next page. You see
`the last sentence, paragraph 10. It starts "Thus"?
` A. Okay.
` Q. (Indicating.)
` A. Oh, "Thus," yeah.
` Q. Could you read that sentence, please?
` A. "Thus, a PHOSITA, viewing disclosure and
`each of the proposed amended claims 24 and 25, would
`understand that truncation of Armandia and Armonk to
`have -- to three characters and displaying 'Arm' on
`the terminal meets the limitation of the truncation
`of 'a truncated portion of each entry in the select
`database field is displayed' - 'Arm' being a
`truncated portion of Armandia and Armonk."
` Q. So do you understand what the purpose of
`the truncation down to Arm is trying to achieve?
` A. Trying to reduce space.
` Q. What kind of space?
` A. Space -- reduce it one line and so reduce
`the space, space on terminal.
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 28 of 45
`
`

`

`Page 85
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` Q. And how does that one line get removed?
` A. Vertically there are -- there are --
`vertically reduce the vertical space.
` Q. But how is the vertical space removed or
`reduced?
` A. By instead of using two -- you just use
`one -- or one line Arm, you know.
` Q. Just use one Arm for what purpose?
` A. For -- for reduce the -- for the -- for
`reduce the space, the space space.
` Q. But what does the one Arm stand for?
` A. It stand for Armandia and Armonk, which is
`being a truncated portion of Armandia and Armonk.
` Q. Okay. Does that differ -- displaying Arm
`as a truncated portion of both Armandia and Armonk,
`does that differ from displaying each truncated
`entry?
` MR. EMERSON: Objection. Form.
` THE WITNESS: Repeat the question again?
`BY MR. HARROP:
` Q. Well, I'll try to rephrase it so I can try
`to get the form right here.
` In the second full sentence of paragraph
`10 on page 5, I'll read it. Page 5. "That is, as a
`PHOSITA would understand, neither proposed amended
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 29 of 45
`
`

`

`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 86
`claim 24 nor 25 recites or requires 'displaying each
`truncated entry.'"
` A. Yes.
` Q. Right.
` A. Yeah.
` Q. You had said that there's not much
`difference -- or I don't want to mischaracterize
`what you were saying, but as I recall, you said
`something to the effect that there's not much
`difference between displaying each truncated entry
`and displaying a truncated portion of each entry.
` MR. EMERSON: Is there a question?
` MR. HARROP: Yeah. I'm -- there is a
`question coming. I just want him to catch up.
`BY MR. HARROP:
` Q. So is displaying each truncated entry
`essentially the same as displaying a truncated
`portion of each entry?
` MR. EMERSON: Object to the form.
` MR. HARROP: Let me --
` THE WITNESS: Yeah.
` MR. HARROP: Let me ask the question
`differently.
`BY MR. HARROP:
` Q. This sentence says, and I'll read this
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 30 of 45
`
`

`

`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 87
`sentence, "That is, as a PHOSITA would understand,
`neither proposed amended claim 24 nor 25 recites or
`requires 'displaying each truncated entry.'"
` What do claims 24 and 25 recite?
` A. Recite just show the truncated --
`truncated terms, yeah, don't need to display --
` [Reporter requests clarification.]
` THE WITNESS: -- do not need to display
`each truncated entry.
`BY MR. HARROP:
` Q. Okay. I think we'll move on to another...
` This next question comes from the
`discussion we had starting on page 11 of your
`declaration.
` A. Yes.
` Q. And Mr. Emerson had you look at this
`paragraph and asked you if you had provided any
`citation to this notion that a POSITA would
`understand -- would not understand that Goldberg
`provides a teaching or suggestion to display each of
`the plurality of entries on a single page of the
`terminal. Hopefully I'm not mischaracterizing what
`you were saying. Okay.
` Now, would you look at the middle of this
`paragraph?
`
`TSG Reporting - Worldwide 877-702-9580
`
`Ex. 1016 / IPR2018-00044
`Unified v. Vilox / Page 31 of 45
`
`

`

`Page 88
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` A. Yeah.
` Q. You see a citation to Exhibit 1014?
` A. 1014, yeah.
` Q. What is Exhibit 1014?
` A. Figure 5a --
` Q. No, no. What is Exhibit 1014?
` A. Oh, that is the patent.
` Q. Patent of what?
` A. Goldberg's patent.
` Q. Okay. And what is the citation that you
`provide there?
` A. Figure 5a to 5g.
` Q. What precedes that?
` A. 1:63.
` [Reporter requests clarification.]
` THE WITNESS: 63.
`BY MR. HARROP:
` Q. Okay. F

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket